203 related articles for article (PubMed ID: 7819052)
1. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.
Imai T; Kimura M; Takeda M; Tomita Y
Br J Cancer; 1995 Jan; 71(1):69-72. PubMed ID: 7819052
[TBL] [Abstract][Full Text] [Related]
2. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas.
Asamoto M; Hasegawa R; Masuko T; Hashimoto Y; Ueda K; Ohtaguro K; Sasaki S; Washida H; Fukushima S
Acta Pathol Jpn; 1990 May; 40(5):322-6. PubMed ID: 2203226
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.
Stewart GD; Bariol SV; Grigor KM; Tolley DA; McNeill SA
BJU Int; 2005 Apr; 95(6):791-3. PubMed ID: 15794784
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
6. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
7. Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors.
Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee GK; Lee KH
Urol Int; 2008; 81(3):306-11. PubMed ID: 18931548
[TBL] [Abstract][Full Text] [Related]
8. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
[TBL] [Abstract][Full Text] [Related]
9. Growth factors and oncogene products in transitional cell carcinoma.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value.
Mellon JK; Lunec J; Wright C; Horne CH; Kelly P; Neal DE
J Urol; 1996 Jan; 155(1):321-6. PubMed ID: 7490879
[TBL] [Abstract][Full Text] [Related]
11. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study.
Chow NH; Liu HS; Yang HB; Chan SH; Su IJ
Virchows Arch; 1997 Jun; 430(6):461-6. PubMed ID: 9230911
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
15. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer.
Lee SE; Chow NH; Chi YC; Tzai TS; Yang WH; Lin SN
Anticancer Res; 1994; 14(3B):1317-24. PubMed ID: 7915094
[TBL] [Abstract][Full Text] [Related]
17. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
18. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.
Sato K; Moriyama M; Mori S; Saito M; Watanuki T; Terada K; Okuhara E; Akiyama T; Toyoshima K; Yamamoto T
Cancer; 1992 Nov; 70(10):2493-8. PubMed ID: 1358427
[TBL] [Abstract][Full Text] [Related]
19. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
Nouri AM; Thompson C; Cannell H; Symes M; Purkiss S; Amirghofran Z
Int J Mol Med; 2000 Oct; 6(4):495-500. PubMed ID: 10998445
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
